Genetic Pathways to Primary and Secondary Glioblastoma

2007/04/24 by Hiroko Ohgaki, Paul Kleihues · 27 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Glioma Diagnosis and Treatment #Cancer Mechanisms and Therapy #Cancer Genomics and Diagnostics

paper · pdf · doi:10.2353/ajpath.2007.070011

Cited by

• High Frequency of Mutations in the PIK3CA Gene Helical and Kinase Coding Regions in a Group of Iranian Patients with High-Grade Glioblastomas: Five Novel Mutations
• Decoding MGMT Methylation: A Step Towards Precision Medicine in Glioblastoma
• An integrated genomic analysis of human glioblastoma multiforme. [europepmc]
• Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. [europepmc]
• IDH1 and IDH2 mutations in gliomas. [europepmc]
• IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. [europepmc]
• An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. [europepmc]
• BMI1 sustains human glioblastoma multiforme stem cell renewal. [europepmc]
• The pathobiology of glioma tumors. [europepmc]
• Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. [europepmc]
• Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. [europepmc]
• Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. [europepmc]
• Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. [europepmc]
• Recent advances in the molecular understanding of glioblastoma. [europepmc]
• Malignant glioma: lessons from genomics, mouse models, and stem cells. [europepmc]
• Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. [europepmc]
• Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. [europepmc]
• ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation. [europepmc]
• Using the molecular classification of glioblastoma to inform personalized treatment. [europepmc]
• The somatic genomic landscape of glioblastoma. [europepmc]
• Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. [europepmc]
• Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. [europepmc]
• Epidemiologic and molecular prognostic review of glioblastoma. [europepmc]
• Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives. [europepmc]
• Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier. [europepmc]
• Combination therapy to checkmate Glioblastoma: clinical challenges and advances. [europepmc]
• Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies. [europepmc]